GlassScriptPhysician profile
Steven Goldenthal
NPI 1013582808
$1,201.51
in general payments reported to CMS, 2019-2025
11 companies · $548 in 2025
The $548 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.94 · 2023: $502 · 2024: $116 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $680.47 | 2023-2025 | Lynx System, Ams 700, General - Kidney Stone Disease |
| Edap Technomed INC | $134.44 | 2025 | |
| Photocure INC | $94.21 | 2025 | Cysview |
| Coloplast Corp | $91.39 | 2023 | Titan |
| Laborie Medical Technologies Corp. | $53.96 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $35.97 | 2022-2023 | Xiaflex |
| Teleflex LLC | $27.96 | 2023 | Urolift |
| Access Pro Medical, LLC | $27.90 | 2025 | Matriderm |
| Endo USA, INC. | $21.88 | 2024 | Xiaflex |
| Olympus America INC. | $17.12 | 2025 | Itind System |
| Procept Biorobotics Corporation | $16.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Goldenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.